welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
Hereditary Colorectal Cancerhttps://www.fapvoice.com/wp-content/uplo...
-
BCIR for People with a Malfunctioning Kock Pouch or J-Pouchhttps://www.youtube.com/watch?v=mO2eC7ou...
-
Special Concerns for People with J-PouchesAfter having an ileoanal reservoir proce...
-
Surgical Prophylaxis in Familial Adenomatous Polyposis: Do Pre-Existing Desmoids Outside the Abdominal Cavity Matter...Desmoid tumours (DT) are myofibroblastic...
-
Efficacy and Safety of Eflornithine (CPP-1X)/Sulindac Combination Therapy Versus Each as Monotherapy in Patients wit...BACKGROUND: Molecular studies suggest i...
-
Thirty Years of the Ileal-Anal Pouch and BeyondStill referred to as a new surgical proc...
-
Rare Coincidence of Familial Adenomatous Polyposis and a Retroperitoneal Fibromyxoid Sarcoma: Report of a CasePURPOSE : Familial adenomatous polyposis...